Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CEND1 |
| Upstream (Parents) |
|---|
| (<<) ADAMTS7 → CEND1 |
| (<<) BAALC → CEND1 |
| (<<) CEP170 → CEND1 |
| (<<) E2F2 → CEND1 |
| (<<) EDNRA → CEND1 |
| (<<) IMPA1 → CEND1 |
| (<<) KCNJ5 → CEND1 |
| (<<) MAL → CEND1 |
| (<<) MAP3K9 → CEND1 |
| (<<) MEF2A → CEND1 |
| (<<) MYL7 → CEND1 |
| (<<) NRAS → CEND1 |
| (<<) PGF → CEND1 |
| (<<) PRSS22 → CEND1 |
| (<<) SOX1 → CEND1 |
| (<<) TCF4 → CEND1 |
| (<<) ZNF205 → CEND1 |
| Downstream (Children) |
|---|
| CEND1 → ALOX15B (>>) |
| CEND1 → GNAS (>>) |
| CEND1 → IL1F9 (>>) |
| CEND1 → LIMK2 (>>) |
| CEND1 → PHOX2A (>>) |
| CEND1 → RYK (>>) |
| CEND1 → SMAD3 (>>) |
| CEND1 → ZNF750 (>>) |
